Business Wire- ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, announced today the closing of a $36 million Series C financing, including existing convertible notes.
Recent Posts
Enterprises portfolio company, Curavi Health, acquires TripleCare
Since its inception in 2016, Curavi Health has focused on addressing the care gaps in …
Read More →
What is the secret sauce of a health care startup?
Last month, Fast Company published an article looking at trends in the digital health startup space and comparing the traits of consumer based tech companies to health care startups.
Read More →